D-0624-2024 Class II Ongoing
FDA drug recall D-0624-2024 was initiated by Eugia US LLC on Jul 26, 2024 and is designated Class II. Reason for recall: Presence of Particulate Matter: Complaint received of a glass particle in the vial. The recall status is ongoing. Affected quantity: 17136 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 7, 2024
- Initiation Date
- Jul 26, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17136 vials
Product description
Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.
Reason for recall
Presence of Particulate Matter: Complaint received of a glass particle in the vial.
Distribution pattern
Nationwide in the USA
Code information
Lot #: CPR230029A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0624-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026